When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

Researchers discovered lariocidin, a lasso peptide antibiotic that kills multidrug-resistant bacteria by binding a novel ...

The novel antibiotic class could be active against the vast majority of multidrug-resistant Enterobacterales infections.

Organisms must adapt to ever-changing environments, otherwise they risk being outcompeted or eliminated. To do this, they have evolved methods for importing DNA from elsewhere and utilizing it for ...

Arrepath Inc. has disclosed UDP-2,3-diacylglucosamine hydrolase (LpxH; bacterial) inhibitors reported to be useful for the treatment of gram-negative bacterial infections.

Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) ...